The main aim of this project is to confirm the association between MYC translocations and patient survival rates. Combining the results of multiple IF and BCL6 FISH and MYC in multivariate analysis to identify a robust phenotype associated with overall survival and disease progression in DLBCL patients treated with R-CHOP. Multiple immunofluorescence study of new markers involved in tumour progression and resistance to treatment.
doctors lead the project
The study is carried out using multiplex immunofluorescence mapping technologies.
In order to successfully achieve the project’s aims, Atrys collaborates with doctors Elías Campo and Lluís Colomo, from the Fundació Clínic per a la Recerca Biomèdica, Hospital Clínic.
The project is co-funded by ACC1Ó-FEDER (European Regional Development Fund) and La Caixa.
Creation of eHealth spaces in hotels through the development of a telemedicine platform.
Read more
